Early predictors of abnormal MRI patterns in asphyxiated infants: S100B protein urine levels
- PMID: 35977430
- DOI: 10.1515/cclm-2022-0559
Early predictors of abnormal MRI patterns in asphyxiated infants: S100B protein urine levels
Abstract
Objectives: The early detection and stratification of asphyxiated infants at higher risk for impaired neurodevelopment is challenging. S100B protein is a well-established biomarker of brain damage, but lacks conclusive validation according to the "gold standard" methodology for hypoxic-ischemic encephalopathy (HIE) prognostication, i.e. brain MRI. The aim of the present study was to investigate the predictive role of urinary S100B concentrations, assessed in a cohort of HIE infants receiving therapeutic hypothermia (TH), compared to brain MRI.
Methods: Assessment of urine S100B concentrations was performed by immunoluminometric assay at first void and at 4, 8, 12, 16, 20, 24, 48, 72, 96, 108 and 120-h after birth. Neurologic evaluation, routine laboratory parameters, amplitude-integrated electroencephalography, and cerebral ultrasound were performed according to standard protocols. Brain MRI was performed at 7-10 days of life.
Results: Overall, 74 HIE neonates receiving TH were included in the study. S100B correlated, already at first void, with the MRI patterns with higher concentrations in infants with the most severe MRI lesions.
Conclusions: High S100B urine levels soon after birth constitute trustable predictors of brain injury as confirmed by MRI. Results support the reliability of S100B in clinical daily practice and open the way to its inclusion in the panel of parameters used for the selection of cases suitable for TH treatment.
Keywords: S100B; brain damage; hypothermia; hypoxic ischemic encephalopathy; perinatal asphyxia.
© 2022 Walter de Gruyter GmbH, Berlin/Boston.
References
-
- Serpero, LD, Bellissima, V, Colivicchi, M, Sabatini, M, Frigiola, A, Ricotti, A, et al.. Next generation biomarkers for brain injury. J Matern Fetal Neonatal Med 2013;26:44–9. https://doi.org/10.3109/14767058.2013.829688.
-
- Gazzolo, D, Pluchinotta, F, Lapergola, G, Franchini, S. The Ca2+binding S100B protein: an important diagnostic and prognostic neurobiomarker in pediatric laboratory medicine. Methods Mol Biol 2019;1929:701–28.
-
- Michetti, F, Corvino, V, Geloso, MC, Lattanzi, W, Bernardini, C, Serpero, L, et al.. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. J Neurochem 2012;120:644–59. https://doi.org/10.1111/j.1471-4159.2011.07612.x.
-
- Bersani, I, Pluchinotta, F, Dotta, A, Savarese, I, Campi, F, Auriti, C, et al.. Early predictors of perinatal brain damage: the role of neurobiomarkers. Clin Chem Lab Med 2020;58:471–86. https://doi.org/10.1515/cclm-2019-0725.
-
- Gazzolo, D, Abella, R, Marinoni, E, di Iorio, R, Volti, GL, Galvano, F, et al.. New markers of neonatal neurology. J Matern Fetal Neonatal Med 2009;22:57–61. https://doi.org/10.1080/14767050903181468.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous